A rare, naturally pluripotent cell.
Discovered in 2010 at Tohoku University, Muse cells are a sparse subpopulation of mesenchymal stem cells, roughly one to three percent of an MSC pool. They carry the pluripotency marker SSEA-3, survive conditions that kill ordinary cells, and migrate to sites of physical distress on their own.
- Mu
- Multilineage-differentiating
- se
- Stress-enduring
In plain terms: cells that survive when nothing else does, and rebuild what they find broken into the tissue it was meant to be.
Four traits that set Muse cells apart.
The properties that make Muse cells the most refined tool in regenerative medicine.
They find injury on their own.
Once introduced, Muse cells migrate through the bloodstream and concentrate at sites of damage, guided by sphingosine-1-phosphate signaling released by injured tissue. No targeted delivery needed.
They become the tissue you need.
Unlike standard MSCs, Muse cells can differentiate into all three germ layers — ectoderm, mesoderm, endoderm — and adopt the cell type appropriate to wherever they arrive. Cartilage in a joint. Neurons in a stroke lesion.
They survive what kills other cells.
Muse cells were originally isolated by subjecting MSCs to severe stress and seeing what survived. That resilience translates to clinical use: more cells reach the injury site alive, more cells integrate.
They do not form tumors.
Despite pluripotency, Muse cells show minimal tumorigenic risk in preclinical and human trials — a key distinction from embryonic stem cells and induced pluripotent stem cells.
Repair that meets the tissue where it is.
Standard mesenchymal cells modulate inflammation and signal repair, but they rely on the body to do the building. Muse cells contribute that signaling and integrate directly into the damaged structure, behaving like the tissue they replace.
- 2010First isolated by Dezawa lab at Tohoku University.
- ~1–3%Of a mesenchymal stem cell pool. Rarity is part of their value.
- 3 layersOf differentiation capacity: ectoderm, mesoderm, endoderm.
Muse cells across our practice.
Used selectively, often alongside UC-MSC and exosome protocols. Indication-led, never bundled.
Direct injection and IV homing.
Knee, hip, shoulder, ankle, and spine. Muse cells integrate into articular cartilage and disc tissue where ordinary MSCs struggle to seat.
See joint protocols →Systemic immune recalibration.
High-dose Muse IV protocols for rheumatoid arthritis, lupus, MS, and inflammatory bowel disease. Pairs with UC-MSC for sustained effect.
See autoimmune protocols →Stroke, SCI, neurodegenerative.
Intravenous and intrathecal Muse cells for post-stroke recovery, spinal cord injury, Parkinson’s, and traumatic brain injury.
See neurological protocols →